Factors Influencing Compliance to Follow-Up After Endovascular Aneurysm Repair.

IF 0.7 4区医学 Q4 PERIPHERAL VASCULAR DISEASE

Vascular and Endovascular Surgery Pub Date : 2023-11-01 Epub Date: 2023-06-12 DOI:10.1177/15385744231183790

Denise Özdemir-van Brunschot, Romina Zerellari, Maria Tevs, David Holzhey, Spiridon Botsios

{"title":"Factors Influencing Compliance to Follow-Up After Endovascular Aneurysm Repair.","authors":"Denise Özdemir-van Brunschot, Romina Zerellari, Maria Tevs, David Holzhey, Spiridon Botsios","doi":"10.1177/15385744231183790","DOIUrl":null,"url":null,"abstract":"Objectives: Regular follow-up after endovascular repair of aortic aneurysm is necessary to detect endoleak and/or migration of the stentgraft. However, absence or incomplete compliance to follow-up is common in this patient population. In this study we will analyse the frequency of non-compliance to post-EVAR follow-up and explore the underlying reasons.Methods: All patients undergoing EVAR for infrarenal aortic aneurysm between 1st January 2011 and 31st December 2020 were included in this retrospective study. Absence of compliance to FU was defined as not showing up at the out-patient clinic; incomplete FU was defined as a surveillance gap of >18 months.Results and conclusion: Non-compliance to follow-up was 35.9% (175 patients). In the multivariate analysis the patients who came with a ruptured aneurysm and patients who needed secondary therapy in the first 30 days more often did not comply with the FU protocol (P = .03 and P < .01). Other studies have confirmed the low attendance to follow-up after EVAR.","PeriodicalId":23530,"journal":{"name":"Vascular and Endovascular Surgery","volume":" ","pages":"878-883"},"PeriodicalIF":0.7000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular and Endovascular Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15385744231183790","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/12 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: Regular follow-up after endovascular repair of aortic aneurysm is necessary to detect endoleak and/or migration of the stentgraft. However, absence or incomplete compliance to follow-up is common in this patient population. In this study we will analyse the frequency of non-compliance to post-EVAR follow-up and explore the underlying reasons.

Methods: All patients undergoing EVAR for infrarenal aortic aneurysm between 1st January 2011 and 31st December 2020 were included in this retrospective study. Absence of compliance to FU was defined as not showing up at the out-patient clinic; incomplete FU was defined as a surveillance gap of >18 months.

Results and conclusion: Non-compliance to follow-up was 35.9% (175 patients). In the multivariate analysis the patients who came with a ruptured aneurysm and patients who needed secondary therapy in the first 30 days more often did not comply with the FU protocol (P = .03 and P < .01). Other studies have confirmed the low attendance to follow-up after EVAR.

查看原文本刊更多论文

影响血管内动脉瘤修复术后随访依从性的因素。

目的：主动脉瘤血管内修复术后有必要定期随访，以检测支架移植物的内漏和/或移位。然而，在这一患者群体中，缺乏或不完全遵守随访是常见的。在这项研究中，我们将分析不遵守EVAR后随访的频率，并探讨根本原因。方法：将2011年1月1日至2020年12月31日期间因肾下主动脉瘤接受EVAR的所有患者纳入本回顾性研究。不遵守FU被定义为没有出现在门诊；不完全FU被定义为>18个月的监测间隔。结果与结论：175例患者不符合随访率为35.9%。在多变量分析中，动脉瘤破裂的患者和前30天需要二次治疗的患者往往不遵守FU方案（P=.03和P<.01）。其他研究证实了EVAR后随访率低。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Vascular and Endovascular Surgery SURGERY-PERIPHERAL VASCULAR DISEASE

CiteScore

1.70

自引率

11.10%

发文量

132

审稿时长

4-8 weeks

期刊介绍： Vascular and Endovascular Surgery (VES) is a peer-reviewed journal that publishes information to guide vascular specialists in endovascular, surgical, and medical treatment of vascular disease. VES contains original scientific articles on vascular intervention, including new endovascular therapies for peripheral artery, aneurysm, carotid, and venous conditions. This journal is a member of the Committee on Publication Ethics (COPE).